Core Thesis Behind Lifecore Biomedical (LFCR): Monetizing Excess Capacity
Greenhaven Road Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Lifecore Biomedical Inc (LFCR)
This company is not actively trading or the ticker does belong to another company in our database now. The symbol (LFCR) is currently associated with the following stock: Lifecore Biomedical Inc. (LFCR)
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.97 | 282,486 | $2,251,413.42 | 2,438,180 | 2022-11-25 | Filing | |
| $7.97 | 345,260 | $2,751,722.20 | 1,972,853 | 2022-11-25 | Filing |
News See All
Lifecore Biomedical Inc (LFCR) Continues Winning Contracts, Ignored by the Market
Laughing Water Capital, an investment management company, released its second-quarter 2026 investor letter. A copy of the letter can be downloaded here.
Can Lifecore Biomedical, Inc. (LFCR) Unlock Long-Term Value Through Expanding Biopharma Collaborations?
TheFly reported on June 16 that Barrington increased its price target on LFCR to $6.50 from $6.00 while reaffirming an Outperform rating on the shares.
12 Best Low-Priced Pharma Stocks to Buy Right Now
Investors looking for large returns without making a sizable initial commitment are still drawn to low-priced companies.
Laughing Water Capital’s Insights on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its first-quarter 2026 investor letter. A copy of the letter can be downloaded here.
What Contributes to Lifecore Biomedical's (LFCR) Distinct Competitive Advantage?
Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter.
Here’s the Analysis of LifeCore’s (LFCR) Growth Potential
Greenhaven Road Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Here’s Why Lifecore Biomedical Inc (LFCR) Declined 22% at the End of Q3
Laughing Water Capital, an investment management company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Does LifeCore (LFCR) Have a High Expected Value?
Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here. A copy of the letter can be downloaded here.
Laughing Water Capital’s View on Lifecore Biomedical (LFCR)
Laughing Water Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center